申请人:MAY & BAKER LIMITED
公开号:EP0042298A1
公开(公告)日:1981-12-23
Indole and indoline derivatives of the formula:
wherein indicates a double bond or a single bond between carbon atoms, R1 represents an alkyl group containing 1 to 6 carbon atoms (which may be substituted by one or more than one of the same type of substituents selected from the hydroxy group, alkenyl groups containing 2 to 5 carbon atoms, and alkanoyloxy groups containing 2 to 7 carbon atoms) or a hydrogen atom, and one of the symbols R2 represents an alkyl group containing 6 to 24 carbon atoms and the other symbol R2 represents an alkyl group containing 1 to 24 carbon atoms, or a hydrogen atom, and R3 reptesents an alkyl group containing 1 to 6 carbon atoms or a hydrogen atom, are new compounds possessing useful pharmacological properties. They are of use in the treatment of diabetes mellitus, hyperlipoproteinaemic states, of atherosclerosis, and of associated disorders. Pharmaceutical compositions containing the compounds are described and so are numerous processes for oreparing the compounds.
式中的吲哚和吲哚啉衍生物:
其中表示碳原子间的双键或单键,R1 表示含 1 至 6 个碳原子的烷基(可被一个或一个以上选自羟基、含 2 至 5 个碳原子的烯基和含 2 至 7 个碳原子的烷酰氧基的同类取代基取代)或氢原子、其中一个符号 R2 代表含 6 至 24 个碳原子的烷基,另一个符号 R2 代表含 1 至 24 个碳原子的烷基或氢原子,而 R3 则代表含 1 至 6 个碳原子的烷基或氢原子。它们可用于治疗糖尿病、高脂蛋白血症、动脉粥样硬化及相关疾病。本文介绍了含有这些化合物的药物组合物,还介绍了许多制备这些化合物的工艺。